The editors of the Methodist DeBakey Cardiovascular Journal extend their deepest gratitude to Neal S. Kleiman, M.D., for his leadership in this special issue on the current status of stents. Dr. Kleiman is the medical director of the cardiac catheterization laboratories and program director of the Interventional Cardiology Fellowship at the Houston Methodist DeBakey Heart & Vascular Center at Houston Methodist Hospital. He is also a professor of cardiology for the Houston Methodist Institute for Academic Medicine and Weill Cornell Medical College.
Dr. Kleiman launched his career in Houston shortly after graduating from Columbia University College of Physicians and Surgeons, completing his internship, residency, and cardiology fellowship at Baylor College of Medicine. He joined the Houston Methodist faculty in 2005.
A prolific researcher, Dr. Kleiman has been the principal or collaborating investigator in more than 100 studies and multicenter trials examining arterial thrombosis, clotting, and percutaneous interventions. His laboratory is nationally recognized as a select site for platelet research where Dr. Kleiman leads studies on the effects of antiplatelet therapy in angioplasty procedures for coronary artery disease. Moreover, Dr. Kleiman has published more than 400 peer-reviewed manuscripts, book chapters, and abstracts in publications including the Journal of the American College of Cardiology, Annals of Thoracic Surgery, Circulation, and the European Heart Journal. He is a valued member of our editorial board, along with those of the Journal of Interventional Cardiology, Circulation, the American Heart Journal, and the Journal of Thrombosis and Thrombolysis.
Dr. Kleiman is active in several professional organizations, including the American Heart Association Council on Clinical Cardiology and Council on Thrombosis, and he is a fellow of the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.